APP-FUBINACA
APP-FUBINACA is a cannabinoid receptor agonist and a derivative of phenylalaninamide-based indazole-3-carboxamide. APP-FUBINACA exhibits neurostimulatory effects.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1185282-03-4
- Fòrmula: C24H21FN4O2
- Peso molecular:416.45
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-12244
BB-22Dopamine Activator/CB1 Receptor Ligand -
HY-117403
AB-FUBICACB1/2 Agonist -
HY-168403
3',4'-Trimethylene-α-pyrrolidinohexanophenone hydrochlorideDrug Derivative -
HY-W714396
bk-EABDI hydrochlorideDrug Derivative -
HY-172065
3,4-Dimethoxy-α-pyrrolidinohexanophenone hydrochlorideDrug Derivative -
HY-168407
7-Methoxy DiPT hydrochlorideTryptamine -
HY-168413
1-(1,3-Benzodioxol-5-yl)-2-(diethylamino)-1-propanone hydrochlorideDrug Derivative
Actividad biológica
Descripciòn
Chemical Information
-
No. CAS 1185282-03-4
-
Peso molecular 416.45
-
Fòrmula C24H21FN4O2
-
SMILES
NC([C@H](CC1=CC=CC=C1)NC(C2=NN(CC3=CC=C(C=C3)F)C4=CC=CC=C24)=O)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Varfaj I, et al. Chromatographic enantioresolution and stereochemical characterization of synthetic cannabinoid receptor agonists with Whelk-O®1 chiral stationary phases under mass spectrometry compatible reversed-phase conditions: A study case with seized samples. Anal Chim Acta. 2024 Aug 15;1317:342901. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
APP-FUBINACA Related Classifications
HY-118245 Related Classifications
Powered by Bioz